2017
DOI: 10.12688/f1000research.11110.1
|View full text |Cite
|
Sign up to set email alerts
|

New insights into the pathogenesis and prevention of tuberous sclerosis-associated neuropsychiatric disorders (TAND)

Abstract: Tuberous sclerosis complex (TSC) is a multi-system disorder resulting from mutations in either the TSC1 or TSC2 genes leading to hyperactivation of mechanistic target of rapamycin (mTOR) signaling. TSC is commonly associated with autism (61%), intellectual disability (45%), and behavioral, psychiatric, intellectual, academic, neuropsychological, and psychosocial difficulties that are collectively referred to as TSC-associated neuropsychiatric disorders (TAND). More than 90% of children with TSC have epilepsy, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
9
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(10 citation statements)
references
References 65 publications
1
9
0
Order By: Relevance
“…mTOR is a key pathway involved in protein synthesis, cell proliferation, and cell growth (Sundberg and Sahin, 2015). In addition to epilepsy and complications to tuber formation throughout the body, approximately 50% of TSC patients meet the criteria for diagnosis of ASD, with a substantial portion of others suffering more subtle neuropsychiatric disturbances (Sundberg and Sahin, 2015; Gipson and Johnston, 2017). Though a previous study linked cerebellar tuber formation to the development of ASD (Weber et al, 2000), more recent efforts have been made to investigate how Purkinje cell function is specifically disrupted through targeted knock-out of TSC1 in Purkinje cells (Tsai et al, 2012; Stoodley et al, 2018).…”
Section: Mouse Models Of Cerebellar Cognitive Disordersmentioning
confidence: 99%
“…mTOR is a key pathway involved in protein synthesis, cell proliferation, and cell growth (Sundberg and Sahin, 2015). In addition to epilepsy and complications to tuber formation throughout the body, approximately 50% of TSC patients meet the criteria for diagnosis of ASD, with a substantial portion of others suffering more subtle neuropsychiatric disturbances (Sundberg and Sahin, 2015; Gipson and Johnston, 2017). Though a previous study linked cerebellar tuber formation to the development of ASD (Weber et al, 2000), more recent efforts have been made to investigate how Purkinje cell function is specifically disrupted through targeted knock-out of TSC1 in Purkinje cells (Tsai et al, 2012; Stoodley et al, 2018).…”
Section: Mouse Models Of Cerebellar Cognitive Disordersmentioning
confidence: 99%
“…28 Moreover, there has been growing interest in the treatment of TAND, through such modalities as mTOR inhibitors despite limited clinical evidence to directly support their use. 12,[30][31][32][33] Education of all health care providers is therefore imperative to ensure that TAND symptoms are better recognized and treated. Future studies should address ways to improve the recognition, knowledge, and treatment of TAND among health care providers as well as patients and their families.…”
Section: Discussionmentioning
confidence: 99%
“…Tuberous sclerosis, for example, is a multisystem disorder resulting from mutations in either the TSC1 or TSC2 genes, leading to abnormal signalling in the mammalian target of rapamycin (mTOR) pathway. The condition is commonly associated with autism in up to 61% of patients, with the presence of renal angiomyolipomata, cystic kidney disease and hypertension in 80% [21]. Phase 3 everolimus trials, EXIST-1 and EXIST-2, demonstrate that everolimus may reduce angiomyolipoma lesion volume and preserve kidney function in most patients [22].…”
Section: Genetic Syndromesmentioning
confidence: 99%